CGH
NTLA icon

Crossmark Global Holdings’s Intellia Therapeutics NTLA Stock Holding History

Crossmark Global Holdings’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,880
Closed -$209K – 1323
2022
Q1 		$209K Buy
+2,880
New +$209K ﹤0.01% 1289